Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
IMRX compared with AGMB: revenue, margins and what each company keeps, and the suppliers and customers both name
IMRX
Immuneering Corp
Change
Mkt cap
Revenue
Revenue
AGMB
Agomab Therapeutics NV
Change
Mkt cap
Revenue
Revenue
vs
Compare
IMRX
Immuneering Corp
vs
AGMB
Agomab Therapeutics NV
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only IMRX
4
LLY
Eli Lilly
supplier
REGN
Regeneron Pharmaceuticals
supplier
—
BioArkive
unlisted
supplier
—
Aventis
unlisted
customer
Shared
0
No disclosed counterparties: AGMB.
Only AGMB
0
None
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
IMRX
Immuneering Corp
Change
3.71
▲
+6.16%
· post 3.71
· delayed
Mkt cap
$225.8M
AGMB
Agomab Therapeutics NV
Change
6.80
▲
+1.19%
· post 6.80
· delayed
After hours
Nov 3 '26
delayed
Mkt cap
$229.6M
vs
Compare
After hours
Nov 3 '26
delayed
IMRX
Immuneering Corp
vs
AGMB
Agomab Therapeutics NV
3.71
▲
+6.16%
post 3.71
delayed
Price
6.80
▲
+1.19%
post 6.80
delayed
$225.8M
Mkt cap
$229.6M
Change
Change
IMRX
3.71
▲
+6.16%
vs
AGMB
6.80
▲
+1.19%
After hours
Nov 3 '26
delayed